MedPage Today on MSN
Ozempic Improves Glycemic Control, Cuts Weight in Schizophrenia Patients
Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback